Searchable abstracts of presentations at key conferences in endocrinology

ea0016p149 | Clinical cases | ECE2008

Giant myelolipoma in a patient affected by 17-α-hydroxylase deficiency and β-thalassemic trait

Sacco Eugenia , Fusco Alessandra , Bianchi Antonio , Lugli Francesca , Tartaglione Linda , Ricerca Bianca Maria , Danza Francesco , Doglietto Giovanni , Pontecorvi Alfredo , De Marinis Laura

Myelolipomas are rare benign tumours resulting from myeloid and adipose mature cells proliferation, both elements have a clonal origin from a common precursor. Myelolipomas predominantly involve the adrenal gland but may develop in extra-adrenal sites. They are hormonally inactive but may coexist with active diseases such as adrenogenital syndrome. They are often asymptomatic but rarely they cause symptoms due to their size or spontaneous retroperitoneal haemorrhage. The myelo...

ea0014oc3.1 | Endocrine tumors & neoplasia | ECE2007

Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion

Zatelli Maria Chiara , Piccin Daniela , Tagliati Federico , Ambrosio Maria Rosaria , Bianchi Antonio , Bondanelli Marta , Schmid Herbert A , Scanarini Massimo , Marinis Laura De , Maira Giulio , Uberti Ettore C degli

Somatostatin (SRIF) analogs have been employed in medical therapy of non-functioning pituitary adenomas (NFA), with contrasting results. Previous evidence showed that SRIF can exert its antiproliferative effects by reducing Vascular Endothelial Growth Factor (VEGF) secretion and action, and that VEGF expression may be related to pituitary tumor growth. The aim of our study was to clarify the possible effects of a multireceptor SRIF ligand on VEGF secretion and cell proliferati...

ea0011p630 | Neuroendocrinology and behaviour | ECE2006

Microalbuminuria as well as insulin sensitivity are improved under octreotide-lar treatment in acromegalic patients

Baldelli R , Gasco V , Pivonello R , Bianchi A , Cimino V , Galenca F , Pontecorvi A , Lombardi G , Ghigo E , Colao A , De Marinis L , Grottoli S

High risk of impaired glucose tolerance and diabetes mellitus is frequently observed in acromegalic patients. Some studies have reported a direct correlation between circulating GH levels and the degree of glucose intolerance. Microalbuminuria clusters with the metabolic syndrome and both conditions predict cardiovascular disease mortality. The reported relationships of microalbuminuria with the individual components of the metabolic syndrome are variable. Aim of this prelimin...

ea0056p751 | Neuroendocrinology | ECE2018

Efficacy and safety of a combinated pasireotide lar, pegvisomant and cabergoline treatment in four cases of aggressive somatotrophinomas

Bima Chiara , Chiloiro Sabrina , Giampietro Antonella , Bianchi Antonio , Piacentini Serena , Milardi Domenico , Tartaglione Tommaso , Lauretti Liverana , Anile Carmelo , Pontecorvi Alfredo , Marinis Laura De

Introduction: A significant number of GH-secreting pituitary adenomas show an aggressive behavior, therefore, when uncontrolled acromegaly persists, a pharmaceutical combination may improve biochemical control, with reduction of disease morbidity and mortality. We aimed to describe the clinical features of four patients successfully treated with a pharmacological combination of pasireotide LAR, pegvisomant and cabergoline.Case reports: Acromegaly was dia...

ea0056p857 | Pituitary - Clinical | ECE2018

HLA celiac haplotypes and Primary Autoimmune Hypophysitis in Caucasian patients

Chiloiro Sabrina , Capoluongo Ettore Domenico , Tartaglione Tommaso , Bianchi Antonio , Giampietro Antonella , Bima Chiara , Angelini Flavia , Arena Vincenzo , Pontecorvi Alfredo , De Marinis Laura

Purpose: Primary hypophysitis is a rare disease, with an autoimmune etiology. As few papers have investigated its genetic, our aim was to evaluate HLA status in a single-center series of patients.Patients and method: A retrospective, longitudinal and cross-sectional study was conducted. Consecutive Caucasian patients, with clinical or histological diagnosis of primary autoimmune hypophysitis (PAH), undergone determination of HLA genotype, anti-pituitary ...

ea0056p875 | Pituitary - Clinical | ECE2018

Efficacy of pasireotide lar in first line somatostatin analogue resistant acromegaly patients: experience from a large and single centre Italian cohort

Chiloiro Sabrina , Giampietro Antonella , Bianchi Antonio , Tartaglione Tommaso , Bima Chiara , Piacentini Serena , Mirra Federica , Donfrancesco Federico , Lauretti Liverana , Anile Carmelo , Pontecorvi Alfredo , De Marinis Laura

Introduction: Pasireotide Lar is a new generation long-acting somatostatin multireceptor ligand, approved for the treatment of first line somatostatin analogue resistant patients. We aimed to review Pasireotide Lar efficacy data, in our series of patients affected by aggressive acromegaly.Patients: A retrospective longitudinal study was conducted on patients with aggressive acromegaly, resistant to first-line somatostatin analogues (SSA) and on treatment...

ea0093oc27 | Oral communication 4: Pituitary and Neuroendocrinology | EYES2023

The role of the GH receptor polymorphisms as a prognostic factor of vertebral fractures in acromegalic patients resistant to first-generation SSAs and treated with Pegvisomant or Pasireotide Lar

Costanza Flavia , Chiloiro Sabrina , Giampietro Antonella , Mattogno Pier Paolo , Infante Amato , Angelini Flavia , Lauretti Liverana , Olivi Alessandro , Pontecorvi Alfredo , Doglietto Francesco , De Marinis Laura , Bianchi Antonio

Background: Acromegaly is associated with skeletal fragility and increased prevalence of vertebral fractures (VF). In recent years several authors tried to investigate predictor markers of bone fragility risk in this endocrine disorder. Two isoforms of GH receptor (GHR) have been described, which differ in the presence or absence of a transcript of exon 3 of the GHR gene. Both isoforms produce a functional receptor, but the exon 3-deleted isoforms (d3-GHR) have greater sensiti...

ea0099ep460 | Pituitary and Neuroendocrinology | ECE2024

Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot monocenter experience

Chiloiro Sabrina , Giampietro Antonella , Infante Amato , Paolo Mattogno Pier , Gulli Consolato , Lauretti Liverana , Olivi Alessandro , Pontecorvi Alfredo , De Marinis Laura , Doglietto Francesco , Bianchi Antonio

Introduction: Skeletal fragility is a relevant and not-reversible complication of acromegaly, involving around 30-40% of patients since the disease diagnosis. Few studies have investigated the effects on skeletal health of medical therapies for acromegaly. We aim to investigate the frequency of incident vertebral fractures (i-VFs) in patients treated with Pasireotide Lar + Pegvisomant (study group), after at least 24 consecutive treatment months and to compare the i-VFs freque...

ea0099ep689 | Pituitary and Neuroendocrinology | ECE2024

Acromegaly and morris syndrome: description of a clinical case

Antonio De Sanctis Simone , Chiloiro Sabrina , Giampietro Antonella , Lauretti Liverana , Gessi Marco , Rindi Guido , Olivi Alessandro , Pontecorvi Alfredo , De Marinis Laura , Doglietto Francesco , Bianchi Antonio

Introduction: The Morris syndrome, is a rare X-linked disorder in which patients with XY chromosomal makeup (corresponding to a male genotype) develop female sexual characteristics. Acromegaly is a rare disease related to excessive production of growth hormone (GH) and insulin growth factor-I (IGF-I). Rarely, acromegaly was reported to be associated to a chromosomal microduplications of Xq26.3, responsible for early onset form of acro-gigantism. However, cases of acromegaly as...

ea0099ep1154 | Pituitary and Neuroendocrinology | ECE2024

The differential diagnosis between cushing’s disease and pseudocushing syndrome in a pre-agonic patient

Antonio De Sanctis Simone , Chiloiro Sabrina , Sofia Tanzarella Eloisa , Bongiovanni Filippo , Giampietro Antonella , De Pascale Gennaro , De Marinis Laura , Antonelli Massimo , Pontecorvi Alfredo , Bianchi Antonio

Introduction: The pseudo-Cushing’s encompass several disorders that can occur in high-stress situations, such as the sepsis, and that show biochemical features like those of Cushing’s syndrome. We present a case with difficult differential diagnosis, for overlapping laboratory findings.Case description: A 74-year-old man was admitted to our hospital for worsening dyspnoea since a month, 15 kilograms weight loss in the previous months, asthenia,...